CAS 119911-68-1
:peptide correlato al gene della calcitonina*frammento 8-37 hum
Descrizione:
Il frammento 8-37 del peptide correlato al gene della calcitonina (CGRP) è un peptide che funge da potente antagonista dei recettori CGRP. Deriva dalla molecola CGRP, che gioca un ruolo significativo in vari processi fisiologici, inclusi la vasodilatazione e la trasmissione del dolore. Il frammento 8-37 si riferisce specificamente a una porzione della sequenza CGRP, che è stata modificata per inibire l'attività del peptide a lunghezza intera. Questo antagonista è particolarmente rilevante nella ricerca relativa alla fisiopatologia dell'emicrania, poiché il CGRP è implicato negli attacchi di emicrania. Il numero CAS 119911-68-1 identifica questo specifico frammento peptidico nelle banche dati chimiche, facilitando il suo utilizzo negli studi scientifici e nelle applicazioni farmaceutiche. In termini di caratteristiche, il frammento 8-37 del CGRP è tipicamente caratterizzato dalla sua struttura peptidica, che include una sequenza di amminoacidi che conferisce la sua attività biologica. Viene spesso sintetizzato per scopi di ricerca e può essere utilizzato in vari contesti sperimentali per esplorare i suoi effetti sulle vie di segnalazione del CGRP e sulle risposte fisiologiche correlate.
Formula:C139H230N44O38
InChI:InChI=1S/C139H230N44O38/c1-66(2)48-86(161-102(193)60-155-113(197)74(17)159-120(204)87(49-67(3)4)168-118(202)83(40-31-45-152-138(147)148)163-123(207)90(53-80-57-151-65-158-80)173-136(220)111(77(20)188)182-131(215)105(145)69(7)8)121(205)169-88(50-68(5)6)122(206)176-96(64-186)129(213)165-84(41-32-46-153-139(149)150)119(203)175-94(62-184)115(199)156-58-101(192)154-59-104(195)177-107(71(11)12)134(218)179-108(72(13)14)133(217)166-82(39-28-30-44-141)117(201)171-91(54-98(142)189)125(209)172-92(55-99(143)190)124(208)170-89(52-79-36-25-22-26-37-79)126(210)180-109(73(15)16)137(221)183-47-33-42-97(183)130(214)181-110(76(19)187)135(219)174-93(56-100(144)191)127(211)178-106(70(9)10)132(216)157-61-103(194)162-95(63-185)128(212)164-81(38-27-29-43-140)116(200)160-75(18)114(198)167-85(112(146)196)51-78-34-23-21-24-35-78/h21-26,34-37,57,65-77,81-97,105-111,184-188H,27-33,38-56,58-64,140-141,145H2,1-20H3,(H2,142,189)(H2,143,190)(H2,144,191)(H2,146,196)(H,151,158)(H,154,192)(H,155,197)(H,156,199)(H,157,216)(H,159,204)(H,160,200)(H,161,193)(H,162,194)(H,163,207)(H,164,212)(H,165,213)(H,166,217)(H,167,198)(H,168,202)(H,169,205)(H,170,208)(H,171,201)(H,172,209)(H,173,220)(H,174,219)(H,175,203)(H,176,206)(H,177,195)(H,178,211)(H,179,218)(H,180,210)(H,181,214)(H,182,215)(H4,147,148,152)(H4,149,150,153)/t74-,75-,76+,77+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,105-,106-,107-,108-,109-,110-,111-/m0/s1
InChI key:NDACAFBDTQIYCQ-YVQXRMNASA-N
SMILES:C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC4=CN=CN4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N)O
Sinonimi:- Calcitonin Gene-Related Peptide-I 8-37, Human
- .alpha.-CGRP (8-37) (human)
- H-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2
Filtra per
Percentuale di purezza
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 5 prodotti.
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
α-CGRP (8-37) (human)
CAS:CGRP and calcitonin cross-react with each other at the levels of their distinct receptors. α-CGRP (8-37) has been described as a selective antagonist for CGRP receptors but not for calcitonin receptors. This fragment thus appears to be a valuable tool for receptor characterization studies.Formula:C139H230N44O38Purezza:97.8%Colore e forma:White LyophilisatePeso molecolare:3125.63HCGRP-(8-37)
CAS:Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonistFormula:C139H230N44O38Purezza:98%Colore e forma:SolidPeso molecolare:3125.59(S)-2-((2S,3R)-2-((S)-1-(L-Valyl-L-threonyl-L-histidyl-L-arginyl-L-leucyl-L-alanylglycyl-L-leucyl-L-leucyl-L-seryl-L-arginyl-L-serylglycylglycyl-L-valyl-L-valyl-L-lysyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-valyl)pyrrolidine-2-carboxamido)-3-hydroxybutanamido)-N1-((S)-1-(((4S,7S,10S,13S)-7-(4-aminobutyl)-13-carbamoyl-4-(hydroxymethyl)-10-methyl-2,5,8,11-tetraoxo-14-phenyl-3,6,9,12-tetraazatetradecyl)amino)-3-methyl-1-oxobutan-2-yl)succinamide
CAS:Formula:C139H230N44O38Purezza:98%Peso molecolare:3125.59CGRP (Human, 8-37)
CAS:CGRP (Human, 8-37) is a peptide derived from the calcitonin gene-related peptide (CGRP) that is found in the nervous system and other tissues in humans. It is a truncated form of the full-length CGRP peptide, consisting of the last 30 amino acids of the CGRP sequence (amino acids 8-37).
CGRP is a potent vasodilator and plays a key role in regulating blood flow and blood pressure. It is also involved in pain perception, inflammation, and neurogenic inflammation. CGRP (Human, 8-37) is an antagonist of CGRP, meaning that it binds to the CGRP receptor without activating it, thereby blocking the effects of CGRP.
CGRP (Human, 8-37) has been used as a research tool to study the physiological and pathological roles of CGRP in various tissues and diseases, such as migraine headaches, cardiovascular diseases, and inflammatory disorders. It has also been investigated as a potential therapeutic agent for these conditions, as well as for the treatment of pain and other neurological disorders.
This product is available as a 0.5mg vial.Formula:C139H230N44O38Purezza:Min. 95%Peso molecolare:3,125.6 g/molα-CGRP (8-37) (HUMAN)
CAS:Formula:C139H230N44O38Purezza:97%Colore e forma:SolidPeso molecolare:3125.5855
